Eli Lil­ly set­tles with med­ical spa over its mar­ket­ing of com­pound­ed tirzepatide

Last year
Pharma
Law

WHO green­lights Takeda's dengue vac­cine as com­pa­ny plans to 're-en­gage' with FDA

Last year
Pharma
FDA+

House com­mit­tee ad­vances bi­par­ti­san bill tar­get­ing Chi­nese biotech sup­pli­ers

Last year
Pharma

LG spins off a new busi­ness that bets big on health soft­ware

Last year
Health Tech

As ad­comm looms, ICER rais­es ques­tions over Lykos’ MD­MA stud­ies

Last year
Pharma
FDA+

Adap­ti­m­mune’s debt fi­nanc­ing deal; Tenaya to cut work­ers

Last year
News Briefing

GoodRx gets back in Kroger's good graces, will work di­rect­ly with gro­cer

Last year
Pharma
Health Tech

Re­searchers con­sid­er why We­govy pro­vides heart ben­e­fits be­yond weight loss

Last year
R&D

Mer­ck KGaA stays pos­i­tive on CD­MO arm’s fu­ture de­spite first-quar­ter slump

Last year
Manufacturing

Up­dat­ed: Black­stone com­mits $300M to a for­mer Mer­ck an­ti­body for asth­ma, COPD

Last year
Financing
Deals

Ei­sai projects near-term Leqem­bi sales 'con­sid­er­ably high­er' than an­a­lyst fore­casts

Last year
Pharma

Bolt Bio­ther­a­peu­tics re­vamps as it drops lead can­cer as­set, changes CEO and trims head­count

Last year
People
R&D

Bio­Marin to lay off 170 staffers af­ter pipeline re­org

Last year
People

Ei­sai heads to FDA with sub­cu­ta­neous ver­sion of Alzheimer’s treat­ment de­vel­oped with Bio­gen

Last year
Pharma
FDA+

As­cendis’ hy­poparathy­roidism drug sad­dled with three-month de­lay at FDA

Last year
Pharma
FDA+

De­struc­tion of doc­u­ments, in­suf­fi­cient da­ta lead FDA to re­ject hep B vac­cine up­date

Last year
Pharma
FDA+

FDA of­fers more clar­i­ty on safe­ty test­ing for cell ther­a­pies

Last year
Cell/Gene Tx
FDA+

WuXi AppTec trims 's­mall per­cent­age' of work­ers at US site as mar­ket shifts

Last year
People
Manufacturing

Pli­ant touts ad­di­tion­al Phase 2a da­ta for oral IPF drug that’s al­ready in a piv­otal study

Last year
R&D

Up­dat­ed: Sands Cap­i­tal rais­es $555M for third life sci­ences fund

Last year
Financing
Startups

Al­lo­gene's $110M of­fer­ing; Apel­lis re­fi­nances

Last year
News Briefing

The End­points Slack in­ter­view: Sid­dhartha Mukher­jee on the doc­tor-writer world­view, AI, and the fu­ture of can­cer

Last year
R&D
AI

Bay­er cuts 1,500 staffers com­pa­ny­wide in cam­paign to re­duce bu­reau­cra­cy

Last year
R&D
Pharma

No­vo Nordisk's We­govy helps keep weight off over four years, new analy­sis shows

Last year
R&D
First page Previous page 157158159160161162163 Next page Last page
A service from the Financial Times